It is evident that transcript levels of ERβ are substantially lower, and that none of the 995 breast tumours, 99 normal breast specimens, or 7 distant metastases exhibit ERβ transcript levels expected to result in protein levels of detectable or functional consequences. The gene discussed is ESR2; the disease is breast neoplasm.